Barrett’s Esophagus Test Identifies High-Risk Patients Missed by Standard Pathology
A study of 85 patients shows the TissueCypher test detected 15% with elevated cancer progression risk despite a non-dysplastic diagnosis.
Category: Uncategorized
Uncategorized
Latest
Uncategorized
Latest
Color Health Partners with CDC to Increase Access to COVID Testing
Color Health is providing free COVID testing through the CDC's Increasing Community Access to Testing program.
Uncategorized
Latest
Ortho Clinical Diagnostics, Thermo Fisher Scientific Partner on QC Solutions
Ortho Clinical Diagnostics has a distribution agreement with Thermo Fisher Scientific to provide and support MAS Quality Controls and LabLink xL Quality Assurance Software through Ortho's Vitros QC Solutions to Vitros System customers worldwide.
Clinical Chemistry
Latest
Global Survey Finds Wide Inconsistencies in Bone Biomarker Testing Practices
A global survey of 231 labs in 41 countries, published by IOF and IFCC, reveals significant inconsistencies in bone biomarker testing methods, reference intervals, and quality assessments, highlighting a need for greater harmonization.
Flow Cytometry
Latest
Blood Test Differentiates Bacterial and Viral Infections in Febrile Infants
A new blood biomarker ratio using neutrophil CD64 and monocyte CD169 demonstrated 100% sensitivity and 96.6% specificity for distinguishing bacterial from viral infections in febrile infants, according to study data presented at EEMC 2024.
Mass Spectrometry
Latest
University Spin-Out Launches to Commercialize Adrenal Cancer and Hormone Disorder Tests
IMS Solutions, a University of Birmingham and Imperial College London spin-out, has raised £1.1 million to commercialize mass spectrometry-based steroid biomarker tests for adrenal cancer and PMOS, with clinical validation underway.
Immunoassay
Latest
Global Study Examines Alzheimer’s Blood Test Performance Across Diverse Populations
A study of more than 15,000 adults found that the blood biomarker remained consistently associated with brain amyloid despite differences in baseline levels across racial and ethnic groups.
Molecular Diagnostics
Latest
Mayo Clinic Laboratories Invests in Pathology Asia to Expand Regional Genomic Testing
Mayo Clinic Laboratories and Pathology Asia Holdings have announced a strategic investment to expand regional access to molecular and genomic diagnostics in Southeast Asia, Australia, and New Zealand.
Point-of-Care
Latest
Ambulance Troponin Testing Helps One-Third of Chest Pain Patients Avoid the ED
Ambulance crews using point-of-care high-sensitivity troponin tests and the HEART score safely avoided ED transport for over one-third of chest pain patients, according to a study presented at the European Emergency Medicine Congress.